ID   IDH3B_HUMAN             Reviewed;         385 AA.
AC   O43837; B2RDR1; D3DVX2; D3DVX3; O95106; Q5JXS8; Q9NQ06; Q9NQ07; Q9NUZ0;
AC   Q9UEX0; Q9UG99;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   18-JUN-2025, entry version 230.
DE   RecName: Full=Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial;
DE   AltName: Full=Isocitric dehydrogenase subunit beta;
DE   AltName: Full=NAD(+)-specific ICDH subunit beta;
DE   Flags: Precursor;
GN   Name=IDH3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), VARIANT VAL-3, AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Heart;
RX   PubMed=10601238; DOI=10.1074/jbc.274.52.36866;
RA   Kim Y.-O., Koh H.-J., Kim S.-H., Jo S.-H., Huh J.-W., Jeong K.-S.,
RA   Lee I.J., Song B.J., Huh T.-L.;
RT   "Identification and functional characterization of a novel, tissue-specific
RT   NAD+-dependent isocitrate dehydrogenase beta subunit isoform.";
RL   J. Biol. Chem. 274:36866-36875(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS B AND C).
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 127-385 (ISOFORM B).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=28098230; DOI=10.1038/srep40921;
RA   Ma T., Peng Y., Huang W., Ding J.;
RT   "Molecular mechanism of the allosteric regulation of the alphagamma
RT   heterodimer of human NAD-dependent isocitrate dehydrogenase.";
RL   Sci. Rep. 7:40921-40921(2017).
RN   [11]
RP   FUNCTION, SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=28139779; DOI=10.1038/srep41882;
RA   Ma T., Peng Y., Huang W., Liu Y., Ding J.;
RT   "The beta and gamma subunits play distinct functional roles in the
RT   alpha2betagamma heterotetramer of human NAD-dependent isocitrate
RT   dehydrogenase.";
RL   Sci. Rep. 7:41882-41882(2017).
RN   [12]
RP   VARIANT RP46 PRO-132.
RX   PubMed=18806796; DOI=10.1038/ng.223;
RA   Hartong D.T., Dange M., McGee T.L., Berson E.L., Dryja T.P., Colman R.F.;
RT   "Insights from retinitis pigmentosa into the roles of isocitrate
RT   dehydrogenases in the Krebs cycle.";
RL   Nat. Genet. 40:1230-1234(2008).
CC   -!- FUNCTION: Plays a structural role to facilitate the assembly and ensure
CC       the full activity of the enzyme catalyzing the decarboxylation of
CC       isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of
CC       the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer
CC       composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have
CC       considerable basal activity but the full activity of the heterotetramer
CC       (containing two subunits of IDH3A, one of IDH3B and one of IDH3G)
CC       requires the assembly and cooperative function of both heterodimers.
CC       {ECO:0000269|PubMed:28139779}.
CC   -!- ACTIVITY REGULATION: The heterotetramer and the heterodimer composed of
CC       IDH3A and IDH3G subunits can be allosterically activated by citrate
CC       (CIT) or/and ADP, and the two activators can act independently or
CC       synergistically. The heterodimer composed of IDH3A and IDH3B subunits
CC       cannot be allosterically regulated and the allosteric regulation of the
CC       heterotetramer is through the IDH3G subunit and not the IDH3B subunit.
CC       The IDH3G subunit contains the allosteric site which consists of a CIT-
CC       binding site and an ADP-binding site, and the binding of CIT and ADP
CC       causes conformational changes at the allosteric site which are
CC       transmitted to the active site in the catalytic subunit (IDH3A) through
CC       a cascade of conformational changes at the heterodimer interface,
CC       leading to stabilization of the isocitrate-binding at the active site
CC       and thus activation of the enzyme. ATP can activate the heterotetramer
CC       and the heterodimer composed of IDH3A and IDH3G subunits at low
CC       concentrations but inhibits their activities at high concentrations,
CC       whereas ATP exhibits only inhibitory effect on the heterodimer composed
CC       of IDH3A and IDH3B subunits. {ECO:0000269|PubMed:28098230,
CC       ECO:0000269|PubMed:28139779}.
CC   -!- SUBUNIT: Heterooligomer of subunits alpha (IDH3A), beta (IDH3B), and
CC       gamma (IDH3G) in the apparent ratio of 2:1:1. The heterodimer
CC       containing one IDH3A and one IDH3B subunit and the heterodimer
CC       containing one IDH3A and one IDH3G subunit assemble into a
CC       heterotetramer (which contains two subunits of IDH3A, one of IDH3B and
CC       one of IDH3G) and further into the heterooctamer.
CC       {ECO:0000269|PubMed:28139779}.
CC   -!- INTERACTION:
CC       O43837-2; PRO_0000014436 [P50213]: IDH3A; NbExp=2; IntAct=EBI-725399, EBI-25820746;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=B;
CC         IsoId=O43837-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=O43837-2; Sequence=VSP_002462;
CC       Name=C;
CC         IsoId=O43837-3; Sequence=VSP_041335;
CC   -!- DISEASE: Retinitis pigmentosa 46 (RP46) [MIM:612572]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies. Retinitis
CC       pigmentosa is characterized by retinal pigment deposits visible on
CC       fundus examination and primary loss of rod photoreceptor cells followed
CC       by secondary loss of cone photoreceptors. Patients typically have night
CC       vision blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field and
CC       eventually central vision as well. {ECO:0000269|PubMed:18806796}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the isocitrate and isopropylmalate
CC       dehydrogenases family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49283; AAB94295.1; -; mRNA.
DR   EMBL; AF023265; AAD09339.1; -; mRNA.
DR   EMBL; AF023266; AAD09340.1; -; mRNA.
DR   EMBL; AK001905; BAA91971.1; -; mRNA.
DR   EMBL; AK315641; BAG38008.1; -; mRNA.
DR   EMBL; AL049712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10579.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10580.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10582.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10583.1; -; Genomic_DNA.
DR   EMBL; BC001960; AAH01960.1; -; mRNA.
DR   EMBL; AL050094; CAB43266.1; -; mRNA.
DR   CCDS; CCDS13031.1; -. [O43837-2]
DR   CCDS; CCDS13032.1; -. [O43837-1]
DR   PIR; T08743; T08743.
DR   PIR; T13147; T13147.
DR   RefSeq; NP_001317692.1; NM_001330763.1.
DR   RefSeq; NP_008830.2; NM_006899.4. [O43837-1]
DR   RefSeq; NP_777280.1; NM_174855.4. [O43837-2]
DR   PDB; 6KDE; X-ray; 3.00 A; B/D=35-374.
DR   PDB; 6KDF; X-ray; 3.05 A; C/D/F/H/J/L/N/P=35-374.
DR   PDB; 6KDY; X-ray; 3.02 A; B/D/F/H=35-374.
DR   PDB; 6KE3; X-ray; 3.31 A; B/D/F/H=35-374.
DR   PDB; 7CE3; X-ray; 3.47 A; D=35-374.
DR   PDB; 8GRB; X-ray; 2.85 A; C/D/F/H/J/L/N/P=35-374.
DR   PDB; 8GRD; X-ray; 2.70 A; B=35-374.
DR   PDB; 8GRU; X-ray; 2.85 A; B/D=35-374.
DR   PDB; 8GS5; X-ray; 4.49 A; B/F/J/N=35-374.
DR   PDBsum; 6KDE; -.
DR   PDBsum; 6KDF; -.
DR   PDBsum; 6KDY; -.
DR   PDBsum; 6KE3; -.
DR   PDBsum; 7CE3; -.
DR   PDBsum; 8GRB; -.
DR   PDBsum; 8GRD; -.
DR   PDBsum; 8GRU; -.
DR   PDBsum; 8GS5; -.
DR   AlphaFoldDB; O43837; -.
DR   SMR; O43837; -.
DR   BioGRID; 109646; 101.
DR   ComplexPortal; CPX-553; Mitochondrial isocitrate dehydrogenase complex (NAD+).
DR   CORUM; O43837; -.
DR   FunCoup; O43837; 2511.
DR   IntAct; O43837; 50.
DR   MINT; O43837; -.
DR   STRING; 9606.ENSP00000482773; -.
DR   DrugBank; DB13874; Enasidenib.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB17097; Vorasidenib.
DR   GlyGen; O43837; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O43837; -.
DR   MetOSite; O43837; -.
DR   PhosphoSitePlus; O43837; -.
DR   SwissPalm; O43837; -.
DR   BioMuta; IDH3B; -.
DR   CPTAC; CPTAC-2740; -.
DR   jPOST; O43837; -.
DR   MassIVE; O43837; -.
DR   PaxDb; 9606-ENSP00000370223; -.
DR   PeptideAtlas; O43837; -.
DR   ProteomicsDB; 49197; -. [O43837-1]
DR   ProteomicsDB; 49198; -. [O43837-2]
DR   ProteomicsDB; 49199; -. [O43837-3]
DR   Pumba; O43837; -.
DR   Antibodypedia; 23248; 259 antibodies from 31 providers.
DR   DNASU; 3420; -.
DR   Ensembl; ENST00000380843.9; ENSP00000370223.4; ENSG00000101365.22. [O43837-1]
DR   Ensembl; ENST00000380851.10; ENSP00000370232.5; ENSG00000101365.22. [O43837-2]
DR   GeneID; 3420; -.
DR   KEGG; hsa:3420; -.
DR   MANE-Select; ENST00000380843.9; ENSP00000370223.4; NM_006899.5; NP_008830.2.
DR   UCSC; uc002wgp.4; human. [O43837-1]
DR   AGR; HGNC:5385; -.
DR   CTD; 3420; -.
DR   DisGeNET; 3420; -.
DR   GeneCards; IDH3B; -.
DR   GeneReviews; IDH3B; -.
DR   HGNC; HGNC:5385; IDH3B.
DR   HPA; ENSG00000101365; Low tissue specificity.
DR   MalaCards; IDH3B; -.
DR   MIM; 604526; gene.
DR   MIM; 612572; phenotype.
DR   OpenTargets; ENSG00000101365; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   VEuPathDB; HostDB:ENSG00000101365; -.
DR   eggNOG; KOG0784; Eukaryota.
DR   GeneTree; ENSGT00950000182989; -.
DR   HOGENOM; CLU_031953_0_1_1; -.
DR   InParanoid; O43837; -.
DR   OMA; TCAHKAN; -.
DR   OrthoDB; 10261637at2759; -.
DR   PAN-GO; O43837; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; O43837; -.
DR   BioCyc; MetaCyc:ENSG00000101365-MONOMER; -.
DR   BRENDA; 1.1.1.41; 2681.
DR   PathwayCommons; O43837; -.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   SABIO-RK; O43837; -.
DR   SignaLink; O43837; -.
DR   SIGNOR; O43837; -.
DR   BioGRID-ORCS; 3420; 24 hits in 1164 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; IDH3B; human.
DR   GeneWiki; IDH3B; -.
DR   GenomeRNAi; 3420; -.
DR   Pharos; O43837; Tbio.
DR   PRO; PR:O43837; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; O43837; protein.
DR   Bgee; ENSG00000101365; Expressed in apex of heart and 208 other cell types or tissues.
DR   ExpressionAtlas; O43837; baseline and differential.
DR   GO; GO:0045242; C:isocitrate dehydrogenase complex (NAD+); IDA:FlyBase.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0004449; F:isocitrate dehydrogenase (NAD+) activity; TAS:ProtInc.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0006102; P:isocitrate metabolic process; IBA:GO_Central.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:ComplexPortal.
DR   FunFam; 3.40.718.10:FF:000001; Isocitrate dehydrogenase [NAD] subunit, mitochondrial; 1.
DR   Gene3D; 3.40.718.10; Isopropylmalate Dehydrogenase; 1.
DR   InterPro; IPR019818; IsoCit/isopropylmalate_DH_CS.
DR   InterPro; IPR004434; Isocitrate_DH_NAD.
DR   InterPro; IPR024084; IsoPropMal-DH-like_dom.
DR   NCBIfam; TIGR00175; mito_nad_idh; 1.
DR   PANTHER; PTHR11835; DECARBOXYLATING DEHYDROGENASES-ISOCITRATE, ISOPROPYLMALATE, TARTRATE; 1.
DR   PANTHER; PTHR11835:SF42; ISOCITRATE DEHYDROGENASE [NAD] SUBUNIT BETA, MITOCHONDRIAL; 1.
DR   Pfam; PF00180; Iso_dh; 1.
DR   SMART; SM01329; Iso_dh; 1.
DR   SUPFAM; SSF53659; Isocitrate/Isopropylmalate dehydrogenase-like; 1.
DR   PROSITE; PS00470; IDH_IMDH; 1.
DR   neXtProt; NX_O43837; -.
DR   PharmGKB; PA29633; -.
DR   TreeFam; TF315033; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disease variant;
KW   Mitochondrion; Proteomics identification; Reference proteome;
KW   Retinitis pigmentosa; Transit peptide; Tricarboxylic acid cycle.
FT   TRANSIT         1..34
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           35..385
FT                   /note="Isocitrate dehydrogenase [NAD] subunit beta,
FT                   mitochondrial"
FT                   /id="PRO_0000014444"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1..177
FT                   /note="MAALSGVRWLTRALVSAGNPGAWRGLSTSAAAHAASRSQAEDVRVEGSFPVT
FT                   MLPGDGVGPELMHAVKEVFKAAAVPVEFQEHHLSEVQNMASEEKLEQVLSSMKENKVAI
FT                   IGKIHTPMEYKGELASYDMRLRRKLDLFANVVHVKSLPGYMTRHNNLDLVIIREQTEGE
FT                   YSSLEHE -> MKMGERWSSLFPFPVSPSCCFLLTQ (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041335"
FT   VAR_SEQ         361..385
FT                   /note="RDMGGYSTTTDFIKSVIGHLQTKGS -> SDMGGYATCHDFTEAVIAALPHP
FT                   (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:10601238"
FT                   /id="VSP_002462"
FT   VARIANT         3
FT                   /note="A -> V (in dbSNP:rs3178817)"
FT                   /evidence="ECO:0000269|PubMed:10601238"
FT                   /id="VAR_022660"
FT   VARIANT         132
FT                   /note="L -> P (in RP46; dbSNP:rs137853020)"
FT                   /evidence="ECO:0000269|PubMed:18806796"
FT                   /id="VAR_054851"
FT   VARIANT         166
FT                   /note="Q -> H (in dbSNP:rs11542741)"
FT                   /id="VAR_049781"
FT   VARIANT         360
FT                   /note="T -> A (in dbSNP:rs8296)"
FT                   /id="VAR_056005"
FT   CONFLICT        127..130
FT                   /note="SYDM -> RTLV (in Ref. 6; CAB43266)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        250
FT                   /note="I -> V (in Ref. 2; BAA91971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        385
FT                   /note="S -> SNL (in Ref. 1; AAD09340)"
FT                   /evidence="ECO:0000305"
FT   STRAND          50..54
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           60..74
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   TURN            87..90
FT                   /evidence="ECO:0007829|PDB:6KDY"
FT   HELIX           93..107
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:6KDY"
FT   HELIX           124..126
FT                   /evidence="ECO:0007829|PDB:6KDY"
FT   HELIX           128..135
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          140..146
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:6KDE"
FT   STRAND          159..165
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           170..172
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          182..190
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           191..207
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   TURN            219..221
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           225..238
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          243..249
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           250..259
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           261..263
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           271..284
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   TURN            288..290
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          292..296
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   STRAND          301..307
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           312..314
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   TURN            315..318
FT                   /evidence="ECO:0007829|PDB:8GRU"
FT   HELIX           323..335
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           339..355
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           361..363
FT                   /evidence="ECO:0007829|PDB:8GRD"
FT   HELIX           369..374
FT                   /evidence="ECO:0007829|PDB:8GRD"
SQ   SEQUENCE   385 AA;  42184 MW;  7324E6CC30A68EE2 CRC64;
     MAALSGVRWL TRALVSAGNP GAWRGLSTSA AAHAASRSQA EDVRVEGSFP VTMLPGDGVG
     PELMHAVKEV FKAAAVPVEF QEHHLSEVQN MASEEKLEQV LSSMKENKVA IIGKIHTPME
     YKGELASYDM RLRRKLDLFA NVVHVKSLPG YMTRHNNLDL VIIREQTEGE YSSLEHESAR
     GVIECLKIVT RAKSQRIAKF AFDYATKKGR GKVTAVHKAN IMKLGDGLFL QCCEEVAELY
     PKIKFETMII DNCCMQLVQN PYQFDVLVMP NLYGNIIDNL AAGLVGGAGV VPGESYSAEY
     AVFETGARHP FAQAVGRNIA NPTAMLLSAS NMLRHLNLEY HSSMIADAVK KVIKVGKVRT
     RDMGGYSTTT DFIKSVIGHL QTKGS
//
